{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:22:42Z","timestamp":1762917762378,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008425","name":"Conseller\u00eda de Cultura, Educaci\u00f3n e Ordenaci\u00f3n Universitaria, Xunta de Galicia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018942","name":"Centro Singular de Investigaci\u00f3n de Galicia","doi-asserted-by":"publisher","award":["ED431G\/09"],"award-info":[{"award-number":["ED431G\/09"]}],"id":[{"id":"10.13039\/501100018942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["AGL-2014-57430-R","AGL2011-23506","BFU2013-43513-R"],"award-info":[{"award-number":["AGL-2014-57430-R","AGL2011-23506","BFU2013-43513-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.antiviral.2017.03.010","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T17:19:52Z","timestamp":1489857592000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Microspheres-prime\/rMVA-boost vaccination enhances humoral and cellular immune response in IFNAR(\u2212\/\u2212) mice conferring protection against serotypes 1 and 4 of bluetongue virus"],"prefix":"10.1016","volume":"142","author":[{"given":"Alejandro","family":"Mar\u00edn-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Calvo-Pinilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-3379","authenticated-orcid":false,"given":"Diego","family":"Barriales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8877-7775","authenticated-orcid":false,"given":"Jose Manuel","family":"Mart\u00ednez-Costas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ortego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.03.010_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0165-2427(94)05410-T","article-title":"Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus","volume":"47","author":"Andrew","year":"1995","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib2","doi-asserted-by":"crossref","first-page":"e13961","DOI":"10.1371\/journal.pone.0013961","article-title":"A\u00a0versatile molecular tagging method for targeting proteins to avian reovirus muNS inclusions. Use in protein immobilization and purification","volume":"5","author":"Brandariz-Nunez","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.03.010_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.11.013","article-title":"Recombinant vaccines against bluetongue virus","volume":"182","author":"Calvo-Pinilla","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2017.03.010_bib4","doi-asserted-by":"crossref","first-page":"e34735","DOI":"10.1371\/journal.pone.0034735","article-title":"Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus","volume":"7","author":"Calvo-Pinilla","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.03.010_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.vaccine.2009.10.027","article-title":"Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(\u2212\/\u2212) mice against lethal bluetongue infection","volume":"28","author":"Calvo-Pinilla","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.03.010_bib6","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.vaccine.2013.03.021","article-title":"Recombinant MVA vaccines: dispelling the myths","volume":"31","author":"Cottingham","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.03.010_bib7","doi-asserted-by":"crossref","first-page":"e70197","DOI":"10.1371\/journal.pone.0070197","article-title":"Ns1 is a key protein in the vaccine composition to protect Ifnar(\u2212\/\u2212) mice against infection with multiple serotypes of African horse sickness virus","volume":"8","author":"de la Poza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.03.010_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virusres.2015.08.005","article-title":"Identification of CD8 T cell epitopes in VP2 and NS1 proteins of African horse sickness virus in IFNAR(\u2212\/\u2212) mice","volume":"210","author":"de la Poza","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2017.03.010_bib9","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin. Vacc. Immunol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/rvsc.1999.0306","article-title":"The ovine cytotoxic T lymphocyte responses to bluetongue virus","volume":"67","author":"Janardhana","year":"1999","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.antiviral.2017.03.010_bib12","first-page":"477","article-title":"Importance of ovine cytotoxic T cells in protection against bluetongue virus infection","volume":"178","author":"Jeggo","year":"1985","journal-title":"Prog. Clin. Biol. Res."},{"issue":"Pt 5","key":"10.1016\/j.antiviral.2017.03.010_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1099\/0022-1317-77-5-997","article-title":"The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants","volume":"77","author":"Jones","year":"1996","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2016.06.019","article-title":"Rabies virus lipopeptide conjugated to a TLR7 agonist improves the magnitude and quality of the Th1-biased humoral immune response in mice","volume":"497","author":"Liu","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.03.010_bib15","doi-asserted-by":"crossref","first-page":"e0131257","DOI":"10.1371\/journal.pone.0131257","article-title":"Full-genome sequencing as a basis for molecular epidemiology studies of bluetongue virus in India","volume":"10","author":"Maan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.03.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcpa.2009.04.003","article-title":"The pathology and pathogenesis of bluetongue","volume":"141","author":"Maclachlan","year":"2009","journal-title":"J.\u00a0Comp. Pathol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2217\/fvl-2016-0061","article-title":"Defeating Bluetongue virus: new approaches in the development of multiserotype vaccines","volume":"11","author":"Mar\u00edn-L\u00f3pez","year":"2016","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.7150\/ijbs.14967","article-title":"Pathological characterization of IFNAR(\u2212\/\u2212) mice infected with bluetongue virus serotype 4","volume":"12","author":"Marin-Lopez","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.antiviral.2017.03.010_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4939-3008-1_9","article-title":"Generation of recombinant modified vaccinia virus Ankara encoding VP2, NS1, and VP7 proteins of bluetongue virus","volume":"1349","author":"Marin-Lopez","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.antiviral.2014.07.008","article-title":"VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(\u2212\/\u2212) mice","volume":"110","author":"Marin-Lopez","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.03.010_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.ento.45.1.307","article-title":"Culicoides biting midges: their role as arbovirus vectors","volume":"45","author":"Mellor","year":"2000","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib22","doi-asserted-by":"crossref","first-page":"e1002477","DOI":"10.1371\/journal.ppat.1002477","article-title":"Identification and characterization of a novel non-structural protein of bluetongue virus","volume":"7","author":"Ratinier","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2017.03.010_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1297-9716-45-30","article-title":"Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes","volume":"45","author":"Rojas","year":"2014","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2017.03.010_bib24","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1016\/j.vaccine.2011.07.061","article-title":"T\u00a0cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep","volume":"29","author":"Rojas","year":"2011","journal-title":"Vaccine"},{"issue":"Pt 12","key":"10.1016\/j.antiviral.2017.03.010_bib25","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1099\/0022-1317-73-12-3051","article-title":"Bluetongue virus proteins","volume":"73","author":"Roy","year":"1992","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000150476","article-title":"Genetically engineered particulate virus-like structures and their use as vaccine delivery systems","volume":"39","author":"Roy","year":"1996","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2017.03.010_bib27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3201\/eid1404.071441","article-title":"Bluetongue epidemiology in the European union","volume":"14","author":"Saegerman","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.03.010_bib28","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1099\/jgv.0.000267","article-title":"Characterization of a second open reading frame in genome segment 10 of bluetongue virus","volume":"96","author":"Stewart","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib29","first-page":"258","article-title":"Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses","volume":"66","author":"Takamatsu","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.antiviral.2017.03.010_bib30","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.4049\/jimmunol.1402918","article-title":"Viremic HIV controllers Exhibit high plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibody responses against HIV-1 p24 associated with greater antibody isotype diversification","volume":"194","author":"Tjiam","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.03.010_bib31","doi-asserted-by":"crossref","first-page":"e5934","DOI":"10.1371\/journal.pone.0005934","article-title":"Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A","volume":"4","author":"Whelan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.03.010_bib32","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.vaccine.2016.03.070","article-title":"A\u00a0rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge","volume":"34","author":"Yendo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.03.010_bib33","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3201\/eid2012.140924","article-title":"Novel bluetongue virus in goats, Corsica, France, 2014","volume":"20","author":"Zientara","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.03.010_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vetmic.2013.01.010","article-title":"Control of bluetongue in Europe","volume":"165","author":"Zientara","year":"2013","journal-title":"Vet. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:32Z","timestamp":1759062392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217300864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":34,"alternative-id":["S0166354217300864"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.03.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microspheres-prime\/rMVA-boost vaccination enhances humoral and cellular immune response in IFNAR(\u2212\/\u2212) mice conferring protection against serotypes 1 and 4 of bluetongue virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}